AMAG Pharmaceuticals (AMAG) Adds Rajiv De Silva and Gino Santini to Board

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced the appointment of Rajiv De Silva and Gino Santini to its board of directors, effective immediately. Mr. De Silva is currently president of Valeant Pharmaceuticals International (NYSE: VRX) and chief operating officer of its Specialty Pharmaceuticals business. Mr. Santini retired in 2010 from a 27-year career at Eli Lilly and Company (NYSE: LLY), where he held a variety of commercial and operational roles, serving most recently as senior vice president, corporate strategy and business development. The appointment of these two independent directors brings the AMAG Board to seven members.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
• Duos Technologies names Dipan Patel as chief operating officer
• BWXT names Suzanne Maddux as new SVP of operations